22-20709921-TTGTC-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The ENST00000255882.11(PI4KA):βc.6156_6159delβ(p.Thr2053SerfsTer4) variant causes a frameshift change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Pathogenic (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.00013 ( 0 hom., cov: 29)
Exomes π: 0.000028 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PI4KA
ENST00000255882.11 frameshift
ENST00000255882.11 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.76
Genes affected
PI4KA (HGNC:8983): (phosphatidylinositol 4-kinase alpha) This gene encodes a phosphatidylinositol (PI) 4-kinase which catalyzes the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. The mammalian PI 4-kinases have been classified into two types, II and III, based on their molecular mass, and modulation by detergent and adenosine. The protein encoded by this gene is a type III enzyme that is not inhibited by adenosine. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Apr 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 22-20709921-TTGTC-T is Pathogenic according to our data. Variant chr22-20709921-TTGTC-T is described in ClinVar as [Pathogenic]. Clinvar id is 1325874.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PI4KA | NM_058004.4 | c.6156_6159del | p.Thr2053SerfsTer4 | frameshift_variant | 53/55 | ENST00000255882.11 | NP_477352.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PI4KA | ENST00000255882.11 | c.6156_6159del | p.Thr2053SerfsTer4 | frameshift_variant | 53/55 | 1 | NM_058004.4 | ENSP00000255882 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 19AN: 151192Hom.: 0 Cov.: 29 FAILED QC
GnomAD3 genomes
AF:
AC:
19
AN:
151192
Hom.:
Cov.:
29
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000281 AC: 41AN: 1457260Hom.: 0 AF XY: 0.0000303 AC XY: 22AN XY: 725300
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
41
AN:
1457260
Hom.:
AF XY:
AC XY:
22
AN XY:
725300
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000132 AC: 20AN: 151288Hom.: 0 Cov.: 29 AF XY: 0.000203 AC XY: 15AN XY: 73846
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
20
AN:
151288
Hom.:
Cov.:
29
AF XY:
AC XY:
15
AN XY:
73846
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Spastic paraplegia 84, autosomal recessive Pathogenic:2
Pathogenic, criteria provided, single submitter | research | Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL) | Apr 27, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 28, 2022 | - - |
Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 28, 2022 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 29, 2022 | This sequence change creates a premature translational stop signal (p.Thr2053Serfs*4) in the PI4KA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PI4KA are known to be pathogenic (PMID: 34415322). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with PI4KA-related condition (PMID: 34415322). ClinVar contains an entry for this variant (Variation ID: 1325874). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at